Acepodia (ROCO:6976) Other Current Liabilities: NT$1.20 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6976 Acepodia Inc ROCO:6976
20 GF Score
Price NT$12.00
! 3 Warning Signs
View Full Analysis

What is Acepodia Other Current Liabilities?

Acepodia ROCO:6976 +1.27% 20 Other Current Liabilities is NT$1.20 Mil as of Jun. 2026. GuruFocus rates ROCO:6976 with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Acepodia's other current liabilities for the quarter that ended in Jun. 2026 was NT$1.20 Mil.

Acepodia's quarterly other current liabilities declined from Jun. 2025 (NT$1.70 Mil) to Dec. 2025 (NT$0.68 Mil) but then increased from Dec. 2025 (NT$0.68 Mil) to Jun. 2026 (NT$1.20 Mil).

Acepodia's annual other current liabilities declined from Dec. 2023 (NT$7.49 Mil) to Dec. 2024 (NT$0.80 Mil) and declined from Dec. 2024 (NT$0.80 Mil) to Dec. 2025 (NT$0.68 Mil).

Acepodia Other Current Liabilities Related Terms

Acepodia Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Acepodia's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acepodia Other Current Liabilities Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 18.44 31.44 7.49 0.80 0.68

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.65 0.80 1.70 0.68 1.20
ROCO:6976
20GF Score
Acepodia Inc ROCO:6976
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acepodia Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of NT$1.20 Mil mean?
Acepodia (ROCO:6976) has a Other Current Liabilities of NT$1.20 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Acepodia.
Is Acepodia's Other Current Liabilities too high?
Acepodia's current Other Current Liabilities is NT$1.20 Mil. Overall, Acepodia has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Acepodia's Other Current Liabilities compare to VRTX and REGN?
Acepodia's Other Current Liabilities of NT$1.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Acepodia. Acepodia's current Other Current Liabilities is NT$1.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acepodia stock overvalued right now?
Acepodia (ROCO:6976) has a current Other Current Liabilities of NT$1.20 Mil. The current Other Current Liabilities is NT$1.20 Mil. Acepodia's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Acepodia (ROCO:6976), the current Other Current Liabilities is NT$1.20 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acepodia Business Description

Address 17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Acepodia Inc is a clinical stage biotechnology company engaged to develop first-in-class cell therapies by using the Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.
20GF Score

Get the complete analysis for ROCO:6976

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$12.00
Price